| Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells ML Lara-Marquez, MS O’Dorisio, TM O’Dorisio, MH Shah, B Karacay The Journal of Immunology 166 (4), 2522-2530, 2001 | 128 | 2001 |
| Defect in Th1-like cells of nonresponders to hepatitis B vaccine MG Chedid, H Deulofeut, DE Yunis, ML Lara-Marquez, M Salazar, ... Human immunology 58 (1), 42-51, 1997 | 100 | 1997 |
| Immunogenetics of human American cutaneous leishmaniasis: study of HLA haplotypes in 24 families from Venezuela ML Lara, Z Layrisse, JV Scorza, E Garcia, Z Stoikow, J Granados, W Bias Human immunology 30 (2), 129-135, 1991 | 93 | 1991 |
| Heparin-binding EGF-like growth factor is present in human amniotic fluid and breast milk MP Michalsky, M Lara-Marquez, L Chun, GE Besner Journal of pediatric surgery 37 (1), 1-6, 2002 | 63 | 2002 |
| Threshold‐stimulated kallikrein activity distinguishes bradykinin‐from histamine‐mediated angioedema ML Lara‐Marquez, SC Christiansen, MA Riedl, J Herschbach, BL Zuraw Clinical & Experimental Allergy 48 (11), 1429-1438, 2018 | 45 | 2018 |
| Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells ML Lara-Marquez, V Mehta, MP Michalsky, JB Fleming, GE Besner Nitric Oxide 6 (2), 142-152, 2002 | 37 | 2002 |
| Heparin-binding EGF-like growth factor decreases inducible nitric oxide synthase and nitric oxide production after intestinal ischemia/reperfusion injury G Xia, M Lara-Marquez, MH Luquette, S Glenn, A Haque, GE Besner Antioxidants and REDOX signaling 3 (5), 919-930, 2001 | 36 | 2001 |
| Analysis of T-cell activation after bronchial allergen challenge in patients with atopicáasthma ML Lara-Marquez, A Deykin, S Krinzman, J Listman, E Israel, H He, ... Journal of allergy and clinical immunology 101 (5), 699-708, 1998 | 34 | 1998 |
| A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects MA Summers, MS O'Dorisio, MO Cox, M Lara-Marquez, EJ Goetzl Journal of Pharmacology and Experimental Therapeutics 306 (2), 638-645, 2003 | 28 | 2003 |
| Atopic asthma: differential activation phenotypes among memory T helper cells ML Lara‐Marquez, MJ Moan, S Cartwright, J Listman, E Israel, DL Perkins, ... Clinical & Experimental Allergy 31 (8), 1232-1241, 2001 | 23 | 2001 |
| Vasoactive Intestinal Peptide (VIP) Receptor Type 2 (VPAC2) is the Predominant Receptor Expressed in Human Thymocytes ML LARA‐MARQUEZ, MSUE O'DORISIO, B Karacay Annals of the New York Academy of Sciences 921 (1), 45-54, 2000 | 23 | 2000 |
| Homeopathic treatment for atopic asthma lung function and immunological outcomes in a randomized clinical trial in Venezuela ML Lara-Marquez, M Pocino, F Rodriguez, GE Carvallo, CF Ortega, ... Proceedings of the 52nd LMHI Congress. Seattle, USA 73, 1997 | 12 | 1997 |
| A longitudinal systems immunologic investigation of acute Zika virus infection in an individual infected while traveling to Caracas, Venezuela AF Carlin, J Wen, EA Vizcarra, M McCauley, A Chaillon, K Akrami, C Kim, ... PLoS neglected tropical diseases 12 (12), e0007053, 2018 | 7 | 2018 |
| Stress and allergic skin diseases—what have we learned? ML Lara-Marquez, KW Kelley Annals of Allergy, Asthma & Immunology 125 (4), 376-377, 2020 | 1 | 2020 |
| Threshold-stimulated plasma kallikrein activity as a biomarker for diagnosis of bradykinin-mediated angioedema B Zuraw, ML Lara-Marquez US Patent App. 16/971,664, 2020 | | 2020 |
| A Type III Hereditary Angioedema 45y-Old Female Patient Presents with a Rare Complication of Acute Atraumatic Compartment Syndrome in Arms and Legs: A Case Report ML Lara-Marquez, MA Riedl Journal of Allergy and Clinical Immunology 135 (2), AB198, 2015 | | 2015 |
| 8. Integrative medicine used for the treatment of viral myopericarditis: A case presentation of an immunocompetent 22 year-old male with stress-induced reactivation of epstein … ML Lara-Marquez, HO Ventura Brain, Behavior, and Immunity 32, e3, 2013 | | 2013 |
| INFLAMMATION AND IMMUNOPHARMACOLOGY-A Lymphocyte-Generated Fragment of Vasoactive Intestinal Peptide with VPAC1 Agonist Activity and VPAC2 Antagonist Effects MA Summers, MS O'Dorisio, MO Cox, M Lara-Marquez, EJ Goetzl Journal of Pharmacology and Experimental Therapeutics 306 (2), 638-645, 2003 | | 2003 |
| CELLULAR IMMUNOLOGY AND IMMUNE REGULATION-Selective Gene Expression and Activation-Dependent Regulation of Vasoactive Intestinal Peptide Receptor Type 1 and Type 2 in Human T Cells ML Lara-Marquez, MS O'Dorisio, TM O'Dorisio, MH Shah, B Karacay Journal of Immunology 166 (4), 2522-2530, 2001 | | 2001 |
| Endogenous heparin-binding EGF-like growth factor: A potential role in fetal and neonatal gastrointestinal physiology MP Michalsky, M Lara-Marquez, L Chun, MT Downing, GE Besner PEDIATRIC RESEARCH 47 (4), 60A-60A, 2000 | | 2000 |
M Sue O'DorisioProfessor of Pediatrics, University of IowaVerified email at uiowa.edu
